Tesamorelin/Ipamorelin 12 2mg Reconstitution: A Step-by-Step Guide

To reconstitute a tesamorelin/ipamorelin 12 2mg vial, inject bacteriostatic water slowly down the inside wall of the vial, swirl gently until the powder fully dissolves, and store the mixed vial in the refrigerator. The "12/2" label almost always means 12 mg of tesamorelin plus 2 mg of ipamorelin, for 14 mg of total peptide per vial. The amount of water you add sets the concentration, and the concentration determines how much liquid shows up on a U-100 insulin syringe.

This is general laboratory handling information, not medical advice. Tesamorelin is FDA-approved as Egrifta for HIV-associated lipodystrophy, but a blended tesamorelin/ipamorelin vial sold online is not an approved drug. Anyone considering human use should talk with a licensed healthcare professional first.

What the 12/2 mg Ratio Really Means

A blend label lists each peptide's mass separately, and the two masses are not interchangeable. In a 12/2 mg vial, roughly 86% of the powder by weight is tesamorelin and about 14% is ipamorelin.

• 12 mg tesamorelin: a growth hormone-releasing hormone (GHRH) analog studied for visceral fat reduction.
• 2 mg ipamorelin: a synthetic five-amino-acid peptide studied as a selective ghrelin receptor agonist.
• 14 mg total: the number you use for all concentration math.

If you are still asking what is ipamorelin peptide, the short answer is that it is a pentapeptide studied for its effects on growth hormone release with less reported hunger stimulation than older secretagogues. It is not FDA-approved for human use in any form.

Supplies You Need Before You Start

• Bacteriostatic water (0.9% benzyl alcohol), room temperature
• Alcohol swabs and a clean, well-lit work surface
• Mixing syringes with 18–21 gauge needles for drawing water
• U-100 insulin syringes for measuring small volumes later
• A sharps container and nitrile gloves

Do not use sterile water for injection if the vial will be stored and re-entered multiple times; bacteriostatic water is the standard choice because the benzyl alcohol slows microbial growth.

Step-by-Step Reconstitution

1. Let the lyophilized vial and the bacteriostatic water sit at room temperature for 10–15 minutes.
2. Wipe the rubber stoppers of both vials with an alcohol swab and let them air dry.
3. Draw your chosen volume of bacteriostatic water into a mixing syringe.
4. Insert the needle at a slight angle so the stream runs down the glass wall, not onto the powder cake.
5. Swirl the vial in a slow circle between your palms. Never shake it, because shaking can denature the peptide.
6. Wait 1–3 minutes and swirl again. The solution should be clear and particle-free.
7. Label the vial with the date, the water volume added, and the resulting concentration.

Concentration Math for a 14 mg Blend

Divide total peptide mass by the milliliters of water added. The table below assumes a single vial containing 12 mg tesamorelin and 2 mg ipamorelin.

On a U-100 insulin syringe, 100 units equals 1 mL. Adding more water spreads the same 14 mg across a larger volume, which makes very small measurements easier to read but never changes the total peptide in the vial.

Use this table to verify concentration only. It is not a dosing guide, and no peptide should be used in humans outside of a supervised clinical setting.

Storage and Shelf Life After Mixing

• Store reconstituted vials at 2–8 °C (36–46 °F), upright, with the stopper up.
• Protect the vial from light; amber vials or a box work well.
• Do not freeze a reconstituted vial, and do not refreeze it after thawing.
• Most research protocols discard reconstituted peptide within 28 days, and many use it within 2–4 weeks.

Keep the lyophilized powder at −20 °C for long-term storage, and let it reach room temperature before opening to avoid condensation. If the mixed solution looks hazy, it may simply be cold, but persistent cloudiness suggests aggregation or contamination, and the vial should be discarded. The same troubleshooting logic people apply when they search aod 9604 cloudy after reconstitution applies here. A clear, colorless solution is the expected result.

Safety, Legality, and Common Mistakes

• Shaking the vial: creates foam and can damage the peptide structure.
• Squirting water onto the powder: the direct stream can shear the peptide; aim for the glass wall.
• Reusing needles: dulls the tip, cores the stopper, and risks contamination.
• Guessing the volume: wrong math is the most common source of wildly inaccurate concentrations.
• Assuming FDA approval: tesamorelin is prescription-only for a specific indication, and ipamorelin is not approved for human use at all.

Reported side effects of GHRH and ghrelin-receptor peptides include injection-site reactions, joint pain, fluid retention, and changes in blood sugar. Anyone with a history of pituitary disease, cancer, or diabetes should not experiment with these compounds without medical supervision.

How This Blend Compares With Other Peptide Stacks

Reconstitution math is identical across vials; only the masses change. A common example is the cjc-1295 without dac 5mg ipamorelin 5mg kit, which follows the same volume-and-concentration rules with 10 mg of total powder instead of 14 mg.

Not every combination belongs in one vial. People who run aod 9604 with tesamorelin typically keep the two peptides separate, because mixing changes how each one is measured and stored. Researchers comparing cjc 1295/ipamorelin effects with tesamorelin protocols usually follow the same sequence: reconstitute, label, refrigerate, and track dates.

The core takeaway is simple. Match the water volume to the concentration you need, write that number on the vial, and keep the cold chain intact from mixing to use.